OCT angiography and sequential quantitative analysis of type 2 neovascularization after ranibizumab therapy

Eye (Basingstoke)

Volumn 29, Issue 7, 2015, Pages 932-935

  Kuehlewein, L ^a,b   Sadda, S R ^a,b   Sarraf, D ^b,c,d  

^a DOHENY EYE INSTITUTE   (United States)

^b JULES STEIN EYE INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; ANGIOGENESIS INHIBITOR; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

AGED; ANGIOGRAPHY; ARTICLE; CASE REPORT; EYE PHOTOGRAPHY; FOLLOW UP; HUMAN; LIGHT; LOW VISION; MALE; OPTICAL COHERENCE TOMOGRAPHY; OPTICAL COHERENCE TOMOGRAPHY DEVICE; OUTCOME ASSESSMENT; QUANTITATIVE ANALYSIS; RETINA BLOOD VESSEL; RETINA DETACHMENT; RETINA MACULA HEMORRHAGE; SPLIT SPECTRUM AMPLITUDE DECORRELATION OPTICAL COHERENCE ANGIOGRAPHY; SUBRETINAL NEOVASCULARIZATION; VERY ELDERLY; VISUAL ACUITY; ANTAGONISTS AND INHIBITORS; CHOROIDAL NEOVASCULARIZATION; FLUORESCENCE ANGIOGRAPHY; INTRAVITREAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; RETINAL HEMORRHAGE; SUBRETINAL FLUID; WET MACULAR DEGENERATION;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; CHOROIDAL NEOVASCULARIZATION; FLUORESCEIN ANGIOGRAPHY; HUMANS; INTRAVITREAL INJECTIONS; MALE; RANIBIZUMAB; RETINAL HEMORRHAGE; SUBRETINAL FLUID; TOMOGRAPHY, OPTICAL COHERENCE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; WET MACULAR DEGENERATION;

EID: 84946021774     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2015.80     Document Type: Article

References (10)

1. Spaide RF, Klancnik Jr JM, Cooney MJ. Retinal vascular layers imaged by fluorescein angiography and optical coherence tomography angiography. JAMA Ophthalmol 2015; 133: 45-50
2. Jia Y, Bailey ST, Wilson DJ, Tan O, Klein ML, Flaxel CJ, et al. Quantitative optical coherence tomography angiography of choroidal neovascularization in age-related macular degeneration. Ophthalmology 2014; 121: 1435-1444
3. Moult E, Choi W, Waheed NK, Adhi M, Lee B, Lu CD, et al. Ultrahigh-speed swept-source OCT angiography in exudative AMD. Ophthalmic Surg Lasers Imaging Retina 2014; 45: 496-505
4. Jia Y, Tan O, Tokayer J, Potsaid B, Wang Y, Liu JJ, et al. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography. Opt Express 2012; 20: 4710-4725
5. Freund KB, Zweifel SA, Engelbert M. Do we need a new classification for choroidal neovascularization in age-related macular degeneration?. Retina 2010; 30: 1333-1349
6. Kraus MF, Potsaid B, Mayer MA, Bock R, Baumann B, Liu JJ, et al. Motion correction in optical coherence tomography volumes on a per A-scan basis using orthogonal scan patterns. Biomed Opt Express 2012; 3: 1182-1199
7. Kraus MF, Liu JJ, Schottenhamml J, Chen CL, Budai A, Branchini L, et al. Quantitative 3D-OCT motion correction with tilt and illumination correction, robust similarity measure and regularization. Biomed Opt Express 2014; 5: 2591-2613
8. Kozak I, Cheng L, Cochran DE, Freeman WR. Phase I clinical trial results of verteporfin enhanced feeder vessel therapy in subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol 2006; 90: 1152-1156
9. Bellou S, Pentheroudakis G, Murphy C, Fotsis T. Anti-angiogenesis in cancer therapy: hercules and hydra. Cancer Lett 2013; 338: 219-228
10. Benjamin LE, Hemo I, Keshet E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 1998; 125: 1591-1598